Related by context. All words. (Click for frequent words.) 81 Prolongs Survival 81 Shows Promise Against 81 Patients Receiving 80 Treated Patients 80 Shows Efficacy 80 Treating Chronic 80 Patients Treated With 80 Improves Survival 79 Effectively Treats 79 Improves Outcomes 79 Meets Primary Endpoint 79 Appears Safe 79 Drug Shows Promise 79 Lowers Risk 79 Rheumatoid Arthritis Patients 79 Investigational Treatment 79 Combination Treatment 79 Drug Candidate 79 Pediatric Patients 79 Cholesterol Lowering Drug 78 Phase 2b Clinical Trial 78 Advanced Melanoma 78 Fungal Infections 78 Pooled Analysis 78 Inhaled Corticosteroids 78 Protein Linked 78 See CLINICAL PHARMACOLOGY 78 Slow Progression 78 Blood Pressure Drug 78 Combo Therapy 78 Demonstrates Positive 78 Proves Effective 78 Long Term Efficacy 78 Epilepsy Drug 77 Reduced Risk 77 Drug Combo 77 Shows Promising 77 Investigational Compound 77 Novel Oral 77 Vaginal Gel 77 Treatment Reduces 77 Single Dose 77 Therapeutic Efficacy 77 Mouse Model 77 Rotavirus Vaccine 77 Hypertensive Patients 77 Oral Fingolimod 77 Prophylactic Treatment 77 FDA Okays 77 Phase III Clinical Trial 77 Slows Progression 77 Fondaparinux 77 Resistant Hypertension 77 Fracture Risk 77 Treatment Shows Promise 77 Patients Treated 77 Adjuvant Treatment 77 Breast Cancer Recurrence 77 Adjuvant Chemotherapy 77 Anti Tumor 77 Potentially Fatal 77 Preclinical Data 77 Study Demonstrates 77 Unfractionated Heparin 76 Transdermal Patch 76 Efficacy Trial 76 Antitumor Activity 76 NDA Submission 76 Investigational Drug 76 Knee Osteoarthritis 76 Therapy Reduces 76 FDA Approvals 76 Drug Prevents 76 Hormone Refractory Prostate Cancer 76 Reduces Risk 76 Phase 2a Trial 76 Initiates Clinical Trial 76 Phase 2b Trial 76 Kidney Transplant Patients 76 Tiotropium 76 Genes Linked 76 Demonstrates Significant 76 Novel Mechanism 76 Kidney Function 76 Therapy Shows Promise 76 Statistically Significant 76 Virus Linked 76 Patients Suffering 76 Clinical Trial Results 76 Gout Drug 76 Osteoporosis Drug 76 Test Detects 76 Vaccine Shows Promise 76 FDA Approves Drug 76 Heart Failure Patients 76 Enlarged Prostate 76 Submits NDA 76 Topical Treatment 76 Demonstrates Sustained 76 Phase 2b Study 76 Antitumor 76 Levels Linked 76 Drug Fails 76 Phase IIb Trial 76 Significantly Improves 76 Gene Linked 76 Inflammatory Markers 76 Completes Patient Enrollment 75 Significantly Improved 75 Complicated Skin 75 Clinical Efficacy 75 Elderly Patients 75 Study Evaluating 75 Investigational Agent 75 Survival Benefit 75 Prostate Cancer Patients 75 HER2 Positive Breast Cancer 75 HCV Protease Inhibitor 75 Obesity Linked 75 Immunomodulatory 75 Lupus Drug 75 IND Application 75 Protease Inhibitor 75 Treatment Naive Patients 75 Is Well Tolerated 75 Disease Progression 75 Reduces Mortality 75 Beta Blocker 75 Septic Shock 75 Statin Drugs 75 Glatiramer Acetate 75 Prognostic Factors 75 Receives Orphan Drug Designation 75 Vaccine Candidate 75 Therapy Improves 75 Initiates Phase III 75 Prostate Cancer Vaccine 75 Overactive Bladder 75 Teva Provides Update 75 Lung Cancer Drug 75 Blood Thinner 75 Increased Mortality 75 Antifungal 75 Improved Survival 75 Antiviral Drugs 75 Chronic Sinusitis 75 Reduces Pain 75 Epilepsy Drugs 75 JAK Inhibitor 75 Migraine Drug 75 Metabolic Disorder 75 Anticancer Activity 75 Sleep Disturbances 75 Phase III Trial 75 Combination REOLYSIN R 74 Novel Treatments 74 Postmenopausal Osteoporosis 74 Fewer Side Effects 74 Severe Asthma 74 Lowers Blood Pressure 74 Data Suggest 74 Renal Cell Carcinoma 74 Vaccine Protects Against 74 Clinical Outcome 74 Efficacious 74 Anti Tumor Activity 74 Antibiotic Resistant 74 Atopic Dermatitis 74 Left Ventricular Hypertrophy 74 Allergic Rhinitis 74 Multiple Myeloma Patients 74 Patients Undergoing 74 Generic Version 74 Attenuates 74 Predict Risk 74 Inhibits 74 Osteoporosis Drugs 74 Interferon Beta 74 Shown Effective 74 Inhaled Steroids 74 Initiate Phase III 74 Pharmacokinetic Study 74 Well Tolerated 74 Bacterial Infection 74 Hepatic Encephalopathy 74 Preclinical Study 74 Skeletal Muscle 74 Novel Inhibitor 74 Phase 2a Clinical Trial 74 Controlled Trial 74 Previously Treated 74 Non Invasive Treatment 74 Muscle Wasting 74 Nicotine Vaccine 74 Presents Preclinical Data 74 Confirms Efficacy 74 Prolongs Life 74 Irritable Bowel 74 Fixed Dose 74 Venous Thromboembolism 74 Kidney Transplant Recipients 74 Meta Analysis 74 Infected Patients 74 Pharmacodynamics 74 Atypical Antipsychotic 74 TNF Blockers 74 Protease Inhibitors 74 Helps Predict 74 Initiate Clinical Trial 74 Demonstrates Statistically Significant 74 Immune Cells 74 Monotherapy 74 Patient Enrollment 74 Demonstrates Potential 74 Therapeutic Potential 74 Elevated Levels 74 Postmenopausal Women 74 Study Casts Doubt 74 Gene Variant 74 Bosutinib 74 RNAi Therapeutic 73 Lupus Nephritis 73 Clinical Trial Data 73 Showed Significant 73 Recurrent Breast Cancer 73 Relapsing Multiple Sclerosis 73 Diabetic Foot Ulcer 73 Increases Risk 73 Artery Disease 73 Nebulized 73 Antiviral Activity 73 Cocaine Addiction 73 Shows Promise 73 Liver Failure 73 Refractory Hodgkin Lymphoma 73 Bone Fracture 73 Chronic Renal Failure 73 Low Dose 73 Tyrosine Kinase Inhibitor 73 Bronchodilator 73 Stem Cell Treatment 73 Thrombotic 73 Osteoarthritis Patients 73 Arthritis Drug 73 Cholesterol Drug 73 Drug Resistant 73 Liver Injury 73 Significantly Reduced 73 Completes Enrollment 73 Study Shows Promise 73 Newly Diagnosed Multiple Myeloma 73 Diabetic Neuropathy 73 Inflammatory Arthritis 73 Successfully Completes Phase 73 Plaque Psoriasis 73 Dose Escalation 73 Successfully Treated 73 Orthostatic Hypotension 73 Myeloma Patients 73 Novel Antibiotic 73 Oral Formulation 73 Premature Infants 73 Progressive Multifocal Leukoencephalopathy 73 Aliskiren 73 Lung Injury 73 Files IND 73 Demonstrated Significant 73 Demonstrate Significant 73 Estrogen Therapy 73 Blood Pressure Drugs 73 Antiplatelet 73 FDA Accepts 73 Metastatic Melanoma 73 Node Positive 73 Refractory Angina 73 Cognitive Impairment 73 Shows Statistically Significant 73 Mouse Models 73 Orally Active 73 Heartburn Drugs 73 Placebo Controlled Study 73 Often Misdiagnosed 73 Hormone Receptor Positive 73 Trial Halted 73 Thiazolidinediones 73 Smallpox Vaccine 73 Malignant Glioma 73 Proven Effective 73 Anticoagulant 73 Placebo Controlled Trial 73 Premenopausal Women 73 Controlled Study 73 Secondary Hyperparathyroidism 73 Mg Usa 73 FDA Clears 73 Blood Clot Risk 73 Acute Ischemic Stroke 73 Antidepressants Linked 73 Study Showed 73 Chronic Bronchitis 73 Immunosuppressant 73 Invasive Fungal Infections 73 Colorectal Cancer Patients 73 Symptom Relief 73 Schizophrenia Treatment 73 Oral Calcitonin 73 Myocardial Ischemia 73 Advanced Prostate Cancer 73 Pivotal Phase III 73 Virus Infection 73 Who Underwent 73 Replacement Therapy 73 Montelukast 73 Muscle Function 73 Study Shows Benefits 72 Demonstrates Potent 72 Improve Outcomes 72 Autologous Stem Cell Transplantation 72 ACE Inhibitors 72 Improve Survival 72 Renal Anemia 72 Tolerability 72 Cholesterol Drugs 72 Anti Clotting Drug 72 Diagnostic Criteria 72 Serious Infections 72 Transplant Patients 72 Granted Orphan Drug 72 Kidney Failure 72 Breast Cancer Cells 72 Pain Relievers 72 Autoimmune Diseases 72 Impairs 72 Dose Ranging Study 72 Genetic Variation 72 Subgroup Analysis 72 Initiates Phase II 72 Critically Ill Patients 72 Liver Damage 72 Blood Clots 72 Iron Deficiency 72 Schizophrenia Drug 72 Sustained Efficacy 72 Trial Evaluating 72 Maven Semantic 72 Hepatotoxicity 72 Urine Test 72 Cardiac Function 72 Hip Fractures 72 Cardiovascular Outcomes 72 Confirmatory Phase 72 Adjunctive Therapy 72 Antipsychotic 72 Cholesterol Lowering 72 Lung Cancer Patients 72 Lung Cancers 72 Double Blind Randomized 72 Chemotherapy Induced 72 Phase III Pivotal Trial 72 Lung Cancer Survival 72 Inflammatory Diseases 72 Randomized Trials 72 Renal Cancer 72 Clinical Trial Evaluating 72 Strongly Linked 72 Mimetics 72 Male Contraceptive 72 Intravenous Formulation 72 Gastric Cancer 72 Migraine Headaches 72 Interferon Gamma 72 Viral Infection 72 Significantly Reduces 72 Study Shows Significant 72 Presents Positive 72 Phase IIb Clinical Trial 72 Disease Modifying 72 Peginterferon Alfa 2a 72 Pivotal Trials 72 Neuroprotective Effects 72 Treatment Regimen 72 Vitamin D Linked 72 Expanded Indication 72 Chronic Cough 72 Immune Responses 72 Polymerase Inhibitor 72 Beneficial Effects 72 Skin Lesions 72 Suppresses 72 Pain Medications 72 Invasive Breast Cancer 72 Acne Drug 72 Bipolar Mania 72 Tumor Growth 72 Autoimmune Disease 72 HER2 Positive 72 FDA Panel Recommends 72 Eszopiclone 72 Cardiotoxicity 72 Cardiovascular Disease Risk 72 Therapeutic Antibody 72 Early Diagnosis 72 Anthracycline 72 Develop Novel 72 Minimally Invasive Treatment 72 Advanced Colorectal Cancer 72 Anti Nausea 72 Anti Inflammatory Drug 72 Ovarian Cancers 72 Hospital Acquired Pneumonia 72 Hormone Therapy 72 Guidelines Issued 72 Myelodysplastic Syndromes 72 Eases Pain 72 Antiepileptic Drug 72 Phase III Trials 72 Anemia Drug 72 Dendritic Cells 72 Initiates Enrollment 72 Cyclooxygenase 2 72 Capsules CII 72 Cognitive Function 72 Subtypes 72 Adenoma 72 Naive Patients 72 Adverse Effects 72 Cancer Recurrence 72 Initiates Clinical 72 Genes Identified 72 Statin Therapy 72 Phase IIa Clinical Trial 72 Uric Acid 72 Progenitor Cells 72 Pafuramidine 72 Extended Release 72 Acute Heart Failure 72 Safinamide 72 Psoriasis Drug 72 First Patient Enrolled 72 Hypercholesterolemia 72 Receives Approvable Letter 72 Pneumococcal Vaccine 72 R lenalidomide 72 Arterial Disease 72 Preterm Delivery 72 FDA Warns Against 72 Gastrointestinal Disorders 72 Diabetic Nephropathy 72 Drug Coated Stents 72 Low Doses 72 Significant Improvements 72 Clostridium difficile Infection 72 Inflammatory Disease 72 Tezampanel 72 Diagnostic Tests 72 Angioedema 72 Potent Antiviral Activity 72 Receives Orphan Drug 72 Pregnancy Linked 72 Suicidality 72 Limb Ischemia 72 Treating Depression 72 Pegylated 71 Anti Inflammatory 71 Double Blind Placebo 71 Gene Variation 71 Combination Therapy 71 Bone Mineral Density 71 Potentially Deadly 71 II Clinical Trial 71 Catheter Associated 71 Chronic Hepatitis B 71 Sustained Reduction 71 Epoetin Alfa 71 Colon Polyps 71 Hormone Replacement 71 Cancer Treatments 71 Testosterone Patch 71 Systemic Delivery 71 Generic Versions 71 Immunotherapeutic 71 Present Preclinical Data 71 Pulmonary Arterial Hypertension 71 Antiplatelet Therapy 71 Adjuvant Therapy 71 Pharmacokinetics PK 71 Effective Than 71 Prospective Randomized 71 Malignant Melanoma 71 Preterm Labor 71 Antihypertensive 71 Recombinant Human 71 Intracerebral Hemorrhage 71 Stomach Cancer 71 Hepatitis C Treatment 71 Fibromyalgia Pain 71 Effective Treatments 71 Relapsing Remitting Multiple Sclerosis 71 Desvenlafaxine Succinate 71 Interferon beta 1a 71 Molecular Basis 71 Weight Loss Supplement 71 MRSA Infections 71 oral prodrug 71 Intravenous Immunoglobulin 71 Skin Disorders 71 Randomized Controlled Trials 71 Severe Sepsis 71 FDA APPROVES 71 Leukemia Cells 71 Pivotal Phase 71 Antigen Specific 71 Peginterferon 71 Kinase Inhibitor 71 RNAi Therapeutics 71 Allergic Reactions 71 Seasonal Influenza Vaccine 71 Mylan Receives Approval 71 CYP#A# substrate 71 Mg Uk 71 Fluorouracil 71 Prevent Stroke 71 Nicotine Addiction 71 Viral Infections 71 Randomized Double blind 71 Bivalirudin 71 Atypical Hemolytic Uremic Syndrome 71 Could Predict 71 Metastatic Colorectal Cancer 71 Contrast Agents 71 Genes Predict 71 Could Prevent 71 Helps Prevent 71 Being Studied 71 Hepatitis B Vaccine 71 Relapsed Multiple Myeloma 71 Diabetic Patients 71 Renal Cell Cancer 71 Migraine Pain 71 First Patient Treated 71 Rheumatoid Arthritis Drug 71 Non Inferiority 71 Obese Patients 71 Brain Metastases 71 Brain Atrophy 71 Hematological Cancers 71 Less Invasive 71 Dose Response 71 Asthma Treatment 71 Hepatitis C Infection 71 Novel Compound 71 Experimental Vaccine 71 Immunosuppression 71 Menopausal Symptoms 71 Beta Blockers 71 Miconazole 71 Atomoxetine 71 Localized Prostate Cancer 71 Launches Generic Version 71 Platelet Inhibition 71 Menopausal Women 71 Small Molecule 71 Erythropoietic 71 Osteoporosis Treatment 71 Tumor Targeting 71 Inhaled Nitric Oxide 71 Medication Adherence 71 Induces 71 Vildagliptin 71 Valvular Heart Disease 71 Immune Cell 71 Phase III Clinical Trials 71 Urinary Tract Infections 71 Fulvestrant 71 JAK2 Inhibitor 71 Contrast Agent 71 Cinacalcet 71 Breast Cancers 71 Respiratory Distress 71 Study Proves 71 Guidelines Recommend 71 Prove Effective 71 Oral Anticoagulant 71 Achieves Primary Endpoint 71 Gum Disease 71 Stem Cell Transplants 71 Haemophilus b Conjugate 71 Aurora Kinase 71 Antiangiogenic 71 Gene Mutation 71 Helps Relieve 71 Treatment Resistant 71 Acute Exacerbations 71 Hemodialysis Patients 71 Thromboembolic 71 Shingles Vaccine 71 Exacerbation 71 Hsp# Inhibitor 71 Regimens 71 Bone Fractures 71 Novel Therapeutic 71 Collaborators Present 71 Investigational Oral 71 Calcium Supplements 71 PRN FDA Approves 71 Glucocorticoid 71 Genes Associated 71 Prevent Breast Cancer 71 Poorly Controlled 71 Sinus Infections 71 Breast Cancer Metastasis 71 Renal Function 71 Skin Cancers 71 Carotid Stenting 71 Diet Linked 71 Brain Scans 71 Vaccine Prevents 71 Prophylaxis 71 Therapeutic Targets 71 Cigarette Smoke 71 Transdermal Delivery 71 Allogeneic 71 C1 Inhibitor 71 Telithromycin 70 Panic Disorder 70 Lower Blood Pressure 70 Community Acquired Pneumonia 70 Modulates 70 Generalized Anxiety Disorder 70 MEK Inhibitor 70 NICE Recommends 70 Genetic Markers 70 Rheumatoid 70 Antibiotic Use 70 #-# Full Text 70 Cervical Cancer Vaccine 70 Inflammatory Disorders 70 Chemotherapeutic Agents 70 Preclinical Efficacy 70 Bone Marrow Cells 70 Eculizumab 70 Excessive Sweating 70 Epidermal Growth Factor Receptor 70 Pre Cancerous 70 Abdominal Pain 70 Ischemic Stroke 70 Treat Heart Failure 70 Genetic Disorder 70 Comorbidities 70 Vitro Activity 70 Postmenopausal 70 Moxifloxacin 70 Vaccine Adjuvant 70 Parenteral Nutrition 70 Cognitive Deficits 70 Hepatitis C Genotype 70 Reperfusion Injury 70 Ranolazine 70 Stress Induced 70 Protein Involved 70 Alternative Treatments 70 Viral Load 70 First Patient Dosed 70 Efficacy Results 70 Genetic Mutation 70 Chronic Hepatitis C 70 Advanced Ovarian Cancer 70 Risedronate 70 Bone Metastases 70 Bazedoxifene 70 Treating Heart Failure 70 Mycophenolate Mofetil 70 Hepatitis C Patients 70 Clinically Proven 70 Leukemias 70 Synthetic Peptide 70 Fibrinogen 70 Immunomedics Announces 70 Anticancer Drug 70 Organ Rejection 70 Aggressive Prostate Cancer 70 Genes Involved 70 Pegylated Interferon 70 Treating Prostate Cancer 70 Melphalan 70 R Saizen R 70 Etanercept 70 Juvenile Idiopathic Arthritis 70 Thromboembolism 70 Vitrasert R 70 Begin Clinical Trials 70 Drug Combinations 70 Cardiovascular Events 70 Tigecycline 70 Sustained Release 70 Premature Aging 70 Cervical Dysplasia 70 Respiratory Infections 70 Holds Promise 70 Severe Acne 70 Fast Track Status 70 Sipuleucel T 70 Aeolus Pharmaceuticals Announces 70 Insulin Glargine 70 Colorectal Adenomas 70 Antipsychotic Medications 70 Anti Angiogenesis 70 Parathyroid Hormone 70 Cardiac Resynchronization 70 Cancer Cells 70 Hepatocellular Carcinoma 70 Contaminant Found 70 Dose Ranging 70 Peptic Ulcer 70 Peginterferon Alfa 2b 70 Pain Medication 70 Phase Ib Clinical Trial 70 Randomized Double Blind 70 Dengue Virus 70 Squamous Cell Carcinoma 70 Migraine Treatment 70 Ovarian Cancer Patients 70 Antithrombotic 70 Thyroid Function 70 Proton Pump Inhibitors 70 Antibiotic Treatment 70 Genetic Tests 70 Cutaneous T 70 Non Alcoholic Steatohepatitis 70 Calcium Vitamin D 70 Antidepressant Drug 70 Non Responders 70 Interferon Alpha 70 Pegloticase 70 Peripheral Arterial 70 Intracerebral 70 Non Alcoholic Fatty 70 Dual Antiplatelet Therapy 70 Post Operative 70 Paclitaxel Carboplatin 70 Improves Quality 70 Weight Loss Drug 70 IND Filing 70 Postmarketing 70 Genetic Marker 70 Epileptic Seizures 70 Lymphoid 70 Gene Variants 70 HDAC Inhibitor 70 Inflammatory Response 70 See WARNINGS 70 Gene Mutations 70 Treatment Naïve 70 Autoimmune Disorders 70 J Clin 70 Therapeutic Vaccine 70 Novel Vaccine 70 Monoclonal Antibody 70 Partial Onset Seizures 70 Preclinical Evaluation 70 Venous Thrombosis 70 Tipranavir 70 Rotavirus Vaccines 70 Smoking Linked 70 Methylprednisolone 70 Genital Warts 70 Malignancies 70 Clinical Evaluation 70 Lymphocytic 70 Adverse Event 70 Long Term Survival 70 Blocked Arteries 70 Tumor Response 70 Commonly Used 70 Antidepressant Use 70 Study Evaluates 70 Renal Insufficiency 70 Clinically Significant 70 Hemorrhagic Stroke 70 Gene Mutation Linked 70 Multidrug 70 Healthbeat Report 70 FASLODEX 70 Helps Smokers Quit 70 Liver Toxicity 70 Pivotal Study 70 Helps Diagnose 70 Emerging Therapies 70 Cholesterol Lowering Drugs 70 Oral Mucositis 70 Solid Tumor 70 Brain Shrinkage 70 Asthma Attacks 70 Colorectal Cancers 70 Renal Impairment 70 Prostate Cancer Treatment 70 Benign Prostatic Hyperplasia 70 Randomized Study 70 PEGylated Fab fragment 70 Peanut Allergy 70 Bicalutamide 70 Nilotinib 70 Unstable Angina 70 Inhalation Solution 70 Help Smokers Quit 70 Mesothelioma Treatment 69 Postherpetic Neuralgia 69 Metastatic Prostate Cancer 69 Prenatal Exposure 69 Skin Infections 69 Versus Placebo 69 Linezolid 69 Respiratory Virus 69 Ebola Vaccine 69 Pivotal Trial 69 Lung Infections 69 Relapsed Refractory 69 Prostate Tumors 69 Renal Artery 69 Cerebrospinal Fluid 69 Plus Ribavirin 69 Intravitreal 69 Cognitive Problems 69 Causes Symptoms 69 Lubiprostone 69 Insulin Sensitivity 69 Cell Transplants 69 Lung Tumors 69 Multiple Sclerosis Rheumatoid Arthritis 69 Receptor Signaling 69 Soft Tissue Sarcoma 69 Cholesterol Levels 69 Combination Vaccine 69 MMR Vaccine 69 Osteoarthritis Pain 69 Ischaemic 69 Medoxomil 69 Adalimumab 69 Radiofrequency Ablation 69 Tablet Formulation 69 Long Term Outcomes 69 Universal Flu Vaccine 69 Adefovir 69 Neoplasms 69 Muscle Cells 69 Depressive Symptoms 69 Breast Cancer Treatment 69 Malaria Vaccine 69 Oncolytic 69 Glucose Control 69 Growth Hormone Deficiency 69 Crit Rev 69 Eradicates 69 Darinaparsin 69 Systemic Sclerosis 69 Erectile Dysfunction Drug 69 Potent Inhibitor 69 Antiarrhythmic 69 Saquinavir 69 Enzyme Replacement Therapy 69 Allergic Asthma 69 Diabetic Foot Ulcers 69 Radiofrequency Ablation RFA 69 Higher Doses 69 Romidepsin 69 Amniotic Fluid 69 Pain Meds 69 Cognitive Decline 69 Treatment Naive 69 Oral Cavity 69 Immune Mediated 69 Radiation Induced 69 Blood Vessels 69 Inhaled Insulin 69 Antipsychotic Drugs 69 Microplasmin 69 GW# [003] 69 Periodontal Disease 69 Fingolimod 69 Immunogenicity 69 Pandemic Flu Vaccine 69 Breast Tumors 69 Bloodstream Infections 69 Multicenter Trial 69 Prognostic Value 69 Factor Receptor 69 Study Sheds Light 69 CDC Recommends 69 Adjunctive 69 Acute Migraine 69 Prostate Cancer Progression 69 Androgen Deprivation Therapy 69 pan HDAC inhibitor 69 ST Segment Elevation 69 Endometrial Cancer 69 Systematic Review 69 Liprotamase 69 Murine Model 69 adalimumab Humira 69 Predict Response 69 Genital Herpes 69 Endothelial Function 69 Valproic Acid 69 Itraconazole 69 Treat Anemia 69 Ridaforolimus 69 Nasal Sprays 69 Primary Endpoint 69 itraconazole Sporanox 69 Newly Diagnosed 69 Left Ventricular 69 Febrile Neutropenia 69 INTEGRILIN R 69 Oral Spray 69 Increased Risk 69 Human Monoclonal Antibody 69 Osteoarthritis Knee Pain 69 Dose Finding 69 Preclinical Models 69 Eur J 69 FDA Approves Generic 69 Short Stature 69 Chemoprevention 69 Posaconazole 69 Prostatic 69 Neuroendocrine Tumors 69 Methylnaltrexone 69 Digestive Tract 69 Hormonal Therapy 69 Esophagitis 69 Antipsychotic Drug 69 Myelofibrosis 69 Lung Cancer Trial 69 PKC# 69 Smooth Muscle 69 Chronic Myeloid Leukemia 69 Signaling Pathways 69 Central Retinal Vein 69 Generic Version Of 69 Anti Depressant 69 Hospitalized Patients 69 Neoadjuvant Chemotherapy 69 Therapeutic Effects 69 alfa 2a 69 Basal Cell 69 Late Breaker 69 Viral Suppression 69 Milestone Payment 69 Liver Tumors 69 Significant Reduction 69 Laryngeal Cancer 69 Signaling Pathway 69 Dasatinib 69 AVI BioPharma Announces 69 Tumor Progression 69 Hyperkalemia 69 Receptor Antagonist 69 Lanthanum Carbonate 69 Decitabine 69 Exposure Linked 69 Lung Cancer Risk 69 Bone Marrow Transplants 69 aripiprazole Abilify 69 Denufosol 69 Surgical Procedures 69 PDUFA Date 69 Carcinomas 69 Bacterial Infections 69 Submits Biologics License Application 69 Initiates Clinical Trials 69 Hospitalization Rates 69 Heart Stents 69 vapreotide acetate 69 Stent Restenosis 69 Zorbtive TM 69 SPRYCEL ® 69 venlafaxine Effexor 69 Sevelamer 69 Licenses Novel 69 Visceral Fat 69 NMDA Receptor 69 Genes Discovered 69 Serious Side Effects 69 Platinol ® 69 Hematological Malignancies 69 Anticancer Drugs 69 Lamotrigine 69 Help Predict 69 Corticosteroid 69 Valopicitabine 69 Seasonal Allergies 69 Electrical Stimulation 69 Predict Breast Cancer 69 TNF Tumor Necrosis Factor 69 ORLive Presents 69 Resubmission 69 Researchers Uncover 69 WARNINGS Myopathy Rhabdomyolysis 69 Carotid Endarterectomy